motif neurotech

It’s a long road for someone suffering from severe mental illness. Antidepressants, TMS sessions at a clinic, ketamine, ECT. A plethora of antiquated options that leave patients still searching for relief. “How is this real?”

Last week, @JTRobinsonLab shared the Medtech MVP stage alongside @AllenBurtonMD - @AbbottNews, J Mocco - Mount Sinai Health System and Jayme Strauss - @PrecisionNeuro_ 📸: @cambridge_VIP 🗺️: Minneapolis, MN

"All we need to do is treat serious mental illness like any other disease." - Jon Nelson, Director of Lived Experience 🎥 : @ARIA_research - @JacquesCarolan 💬 : “Breaking the Stigma of Mental Illness” 🇬🇧 : London, UK

Please help us welcome Jake Wiederin as our Head of Medical Device Manufacturing! With 15+ years of experience in the manufacturing and commercialization of Class III implantable medical devices, Jake brings deep expertise in neuromodulation & operations integration to Motif.

Our next #InterfaceNeuroGT session highlighted cutting-edge techniques for measuring and manipulating sensorimotor and cognitive behavior — across species and across scales. Sponsored by @ParkinsonsGT and chaired by @DrACSinger.

Anhedonia is the inability to experience pleasure or joy—it's a common symptom of various mental health conditions, including major depressive disorder (MDD). In this clip from our latest short film, 'Reaching the Light Together,' hear Miskat's story—from experiencing creative…

Curious about how we are miniaturizing mental health treatment? @JTRobinsonLab explains how rare magnetoelectric materials allow us to wirelessly generate a lot of energy and transfer data from a small device. Happy #ScienceFriday - here's some physics to nerd out on 🤓

Last month, we were honored to present our advancements at the invitation-only MARS conference hosted by Jeff Bezos. @JTRobinsonlab had a chance to present our prototype DOT and progress in building neural devices to help people live better lives. 📸: Benjamin Rose Photography

Check out the view from Deep Tech Week NYC this week 🏙️ 😮‍💨. @JTRobinsonLab shared the stage with some great neurotech leaders for an evening of networking and industry collaboration. Shoutout to @PsymedVentures, @DataJointNeuro, and Actual VC for hosting such a wonderful night!

"We call the company Motif because its the pattern of brain activity which underlies many forms of mental illness. If we can play back restorative patterns of brain activity, restorative 'motifs', people can recover from mental illness." - @JTRobinsonLab

Our COO Nick Halper recently sat down with @avileddie on @IntotheChange Podcast 🔊 They discuss DOT - Motif's therapeutic neural device technology and our place in the broader brain-computer interfaces (#BCI) ecosystem. youtu.be/XqiiCWw1Cr0?si…

Please join us in congratulating Julie Goode on her promotion to Vice President of Clinical Affairs! Julie will continue to lead our clinical research efforts as we prepare for clinical trials in 2025. 🚀

👀

📽️ Check out @JTRobinsonLab on stage last month at @CES Jacob and the panel explore the potential of neural devices to help everyone live a better life🧠

We're thrilled to formally welcome Joshua Woods, PhD as our Senior Electrical Engineer! Josh has been integral in our world for some time now. His doctoral work at @JTRobinsonLab @RiceUniversity included pioneering the first DOT and magnetoelectric power for neural networks.

We brought the whole team to Houston this week for our 2025 Strategy Summit. The team synergy is palpable and we're so excited for everything ahead of us this year 🧠🛫